These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35953572)

  • 21. Optimizing the use of Paxlovid in clinical practice.
    McCarthy MW
    Drugs Today (Barc); 2022 Nov; 58(11):539-546. PubMed ID: 36422515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficacy of paxlovid in elderly patients infected with SARS-CoV-2 omicron variants: Results of a non-randomized clinical trial.
    Zhong W; Jiang X; Yang X; Feng T; Duan Z; Wang W; Sun Z; Chen L; Nie X; Zhu C; Zhang W; Li Y
    Front Med (Lausanne); 2022; 9():980002. PubMed ID: 36148451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SARS
    Chen M; Guo T; Zhou Z; Chen D; Zhou H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 47(12):1775-1780. PubMed ID: 36748391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: A retrospective cohort study.
    Qian G; Wang X; Patel NJ; Kawano Y; Fu X; Cook CE; Vanni KMM; Kowalski EN; Banasiak EP; Bade KJ; Srivatsan S; Williams ZK; Todd DJ; Weinblatt ME; Wallace ZS; Sparks JA
    medRxiv; 2022 Oct; ():. PubMed ID: 36324801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic Surveillance of SARS-CoV-2 M
    Lee JT; Yang Q; Gribenko A; Perrin BS; Zhu Y; Cardin R; Liberator PA; Anderson AS; Hao L
    mBio; 2022 Aug; 13(4):e0086922. PubMed ID: 35862764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paxlovid-like nirmatrelvir/ritonavir fails to block SARS-CoV-2 transmission in ferrets.
    Cox RM; Lieber CM; Wolf JD; Karimi A; Lieberman NAP; Sticher ZM; Roychoudhury P; Andrews MK; Krueger RE; Natchus MG; Painter GR; Kolykhalov AA; Greninger AL; Plemper RK
    bioRxiv; 2022 Nov; ():. PubMed ID: 36451893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Azvudine versus paxlovid for oral treatment of COVID-19 in Chinese patients.
    Su P; Yang CX; Wang XG
    BMC Infect Dis; 2024 Jan; 24(1):44. PubMed ID: 38172735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug-drug interaction between paxlovid and tacrolimus in a patient with myasthenia gravis and SARS-CoV-2 infection.
    Chen Y; Wan W; Yao X; Guan Y
    J Neuroimmunol; 2023 Dec; 385():578245. PubMed ID: 37992586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Viral and Symptom Rebound in Untreated COVID-19 Infection.
    Deo R; Choudhary MC; Moser C; Ritz J; Daar ES; Wohl DA; Greninger AL; Eron JJ; Currier JS; Hughes MD; Smith DM; Chew KW; Li JZ;
    medRxiv; 2022 Aug; ():. PubMed ID: 35982660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paxlovid administration in elderly patient with COVID-19 caused by Omicron BA.2.0: A case report.
    Zhang L; Zhang S; Han J; Yi Y; Zhou H; Li J
    Medicine (Baltimore); 2022 Nov; 101(45):e31361. PubMed ID: 36397388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COVID-19 rebound after oral treatment in a nursing home facility: A case series.
    Betrosian AP; Christou SM; Kalathaki S
    Infect Med (Beijing); 2022 Dec; 1(4):285-287. PubMed ID: 38013912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Network Pharmacology and Bioinformatics Analysis Identifies Potential Therapeutic Targets of Paxlovid Against LUAD/COVID-19.
    Zhang W; Yang Z; Zhou F; Wei Y; Ma X
    Front Endocrinol (Lausanne); 2022; 13():935906. PubMed ID: 36157452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of Paxlovid in Reducing Severe Coronavirus Disease 2019 and Mortality in High-Risk Patients.
    Najjar-Debbiny R; Gronich N; Weber G; Khoury J; Amar M; Stein N; Goldstein LH; Saliba W
    Clin Infect Dis; 2023 Feb; 76(3):e342-e349. PubMed ID: 35653428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of Paxlovid, an Oral Antiviral Drug, Against the Omicron BA.5 Variant in Korea: Severe Progression and Death Between July and November 2022.
    Kim JM; Yoo MG; Bae SJ; Kim J; Lee H
    J Korean Med Sci; 2023 Jul; 38(27):e211. PubMed ID: 37431541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of paxlovid (nirmatrelvir/ritonavir) in the treatment of COVID-19: An updated meta-analysis and trial sequential analysis.
    Tian H; Yang C; Song T; Zhou K; Wen L; Tian Y; Tang L; Xu W; Zhang X
    Rev Med Virol; 2023 Sep; 33(5):e2473. PubMed ID: 37485774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Viral Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Omicron Infection in mRNA-Vaccinated Individuals Treated and Not Treated with Nirmatrelvir-Ritonavir.
    Dai EY; Lee KA; Nathanson AB; Leonelli AT; Petros BA; Brock-Fisher T; Dobbins ST; MacInnis BL; Capone A; Littlehale N; Boucau J; Marino C; Barczak AK; Sabeti PC; Springer M; Stephenson KE
    medRxiv; 2022 Aug; ():. PubMed ID: 35982651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [COVID-19 treated with oral Nirmatrelvir-Ritonavir in 3 children].
    Shi S; Dong N; Ding Y; Wang C; Yuan L; Fang YS; Wang BJ; Niu YH; Wei ZZ; Pu T; Dong XY; Lu Q
    Zhonghua Er Ke Za Zhi; 2022 Nov; 60(11):1168-1171. PubMed ID: 36319152
    [No Abstract]   [Full Text] [Related]  

  • 38. Neutropenia after the coadministration of clozapine and nirmatrelvir-ritonavir in a patient with SARS-CoV-2 infection: A case report with a literature review.
    Liu CI; Goh KK; Chen CH
    Front Psychiatry; 2022; 13():1096006. PubMed ID: 36620672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COVID drug Paxlovid was hailed as a game-changer. What happened?
    Kozlov M
    Nature; 2023 Jan; 613(7943):224-225. PubMed ID: 36599997
    [No Abstract]   [Full Text] [Related]  

  • 40. The feasibility, safety, and efficacy of Paxlovid treatment in SARS-CoV-2-infected children aged 6-14 years: a cohort study.
    Yan G; Zhou J; Zhu H; Chen Y; Lu Y; Zhang T; Yu H; Wang L; Xu H; Wang Z; Zhou W
    Ann Transl Med; 2022 Jun; 10(11):619. PubMed ID: 35813342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.